Aminophylline Use in Pregnant Women for Asthma Management

Primary Indication: Asthma Management

• The American College of Allergy, Asthma, and Immunology recommends theophylline as an alternative therapy for mild persistent asthma, requiring careful dose titration and serum level monitoring to maintain concentrations between 5-12 mcg/mL 1, 2, 3
• Preferred treatments are inhaled corticosteroids, which have superior effectiveness and safety data in pregnancy 1, 2, 3
• Theophylline should be considered only when inhaled corticosteroids are contraindicated or not tolerated, or when the patient was well-controlled on theophylline prior to pregnancy 1, 2, 3

Critical Safety Requirements

• Mandatory serum level monitoring is required to maintain therapeutic range of 5-12 mcg/mL, with careful dose titration due to narrow therapeutic window 1, 2, 3
• Monitoring for drug-drug interactions, particularly with erythromycin, is essential to prevent toxic ranges 1, 2, 3

Key Clinical Considerations

• The European Society of Cardiology notes that the benefit of controlled asthma outweighs medication risks, and uncontrolled asthma poses definite risks to mother and fetus 6, 7
• In emergencies, drugs not routinely recommended during pregnancy should not be withheld if needed for maternal health 6, 7
• The potential benefit must be weighed against the drug's potential risks, with consideration of the patient's individual circumstances and medical history 6, 7